RS50065B - Derivati benzofurana, njihova izrada i upotreba - Google Patents

Derivati benzofurana, njihova izrada i upotreba

Info

Publication number
RS50065B
RS50065B YUP-384/01A YU38401A RS50065B RS 50065 B RS50065 B RS 50065B YU 38401 A YU38401 A YU 38401A RS 50065 B RS50065 B RS 50065B
Authority
RS
Serbia
Prior art keywords
alkyl
cycloalkyl
group
indolyl
alkynyl
Prior art date
Application number
YUP-384/01A
Other languages
English (en)
Inventor
Kim Andersen
Thomas Ruhland
Mario Rottlander
Klaus Peter Bogeso
Henrik Pedersen
Robert J.M. Dancer
Original Assignee
H. Lundbeck A/S.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S., filed Critical H. Lundbeck A/S.,
Publication of YU38401A publication Critical patent/YU38401A/sh
Publication of RS50065B publication Critical patent/RS50065B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
YUP-384/01A 1998-12-08 1999-12-03 Derivati benzofurana, njihova izrada i upotreba RS50065B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11136098P 1998-12-08 1998-12-08
DKPA199801631 1998-12-09

Publications (2)

Publication Number Publication Date
YU38401A YU38401A (sh) 2005-06-10
RS50065B true RS50065B (sr) 2009-01-22

Family

ID=43768792

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-384/01A RS50065B (sr) 1998-12-08 1999-12-03 Derivati benzofurana, njihova izrada i upotreba

Country Status (18)

Country Link
EP (1) EP1137644B9 (sr)
JP (1) JP2002531556A (sr)
AR (1) AR021509A1 (sr)
AT (1) ATE249451T1 (sr)
AU (1) AU759248B2 (sr)
CA (1) CA2353618A1 (sr)
CZ (1) CZ20012041A3 (sr)
DE (1) DE69911243T2 (sr)
DK (1) DK1137644T3 (sr)
ES (1) ES2204175T3 (sr)
HU (1) HUP0104510A3 (sr)
IL (1) IL143082A (sr)
ME (1) MEP38508A (sr)
PT (1) PT1137644E (sr)
RS (1) RS50065B (sr)
SE (1) SE1137644T5 (sr)
SI (1) SI1137644T1 (sr)
WO (1) WO2000034263A1 (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EA008373B1 (ru) * 2000-07-07 2007-04-27 Х. Лундбекк А/С Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом
EA008372B1 (ru) * 2000-07-07 2007-04-27 Х.Лундбекк А/С Применение эсциталопрама для лечения расстройства, связанного с социальной тревогой
WO2002008216A1 (en) * 2000-07-21 2002-01-31 H. Lundbeck A/S Novel compounds and their use as glycine transport inhibitors
WO2002020493A2 (en) * 2000-09-06 2002-03-14 Chugai Seiyaku Kabushiki Kaisha A traceless solid-phase synthesis of 2-imidazolones
US7235569B2 (en) 2003-05-02 2007-06-26 Wyeth Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use
US7276603B2 (en) 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
BR112023025340A2 (pt) * 2021-06-02 2024-02-20 Compass Pathfinder Ltd Compostos de triptamina fluorada, análogos dos mesmos e métodos usando os mesmos
WO2025104490A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (sr) * 1965-03-18
GB1173312A (en) * 1966-03-17 1969-12-10 Kefalas As Heterocyclic Compounds
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
CN1046507C (zh) * 1993-12-28 1999-11-17 法玛西雅厄普约翰美国公司 用于治疗中枢神经系统和心血管疾病的杂环化合物
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JP2002531556A (ja) 2002-09-24
SI1137644T1 (en) 2003-12-31
EP1137644B9 (en) 2004-03-17
EP1137644A1 (en) 2001-10-04
HUP0104510A2 (hu) 2002-04-29
DE69911243T2 (de) 2004-07-15
DE69911243D1 (de) 2003-10-16
EP1137644B1 (en) 2003-09-10
CA2353618A1 (en) 2000-06-15
ES2204175T3 (es) 2004-04-16
HUP0104510A3 (en) 2003-01-28
MEP38508A (en) 2011-02-10
ATE249451T1 (de) 2003-09-15
IL143082A (en) 2004-06-20
PT1137644E (pt) 2004-01-30
AU759248B2 (en) 2003-04-10
DK1137644T3 (da) 2003-12-08
CZ20012041A3 (cs) 2001-10-17
IL143082A0 (en) 2002-04-21
AR021509A1 (es) 2002-07-24
WO2000034263A1 (en) 2000-06-15
SE1137644T5 (sr) 2004-05-11
AU1503600A (en) 2000-06-26
SE1137644T3 (sr) 2003-12-02
YU38401A (sh) 2005-06-10

Similar Documents

Publication Publication Date Title
RS50065B (sr) Derivati benzofurana, njihova izrada i upotreba
PT955299E (pt) Novos derivados benzotiofenicos benzofuranicos e indolicos processo para a sua preparacao e as composicoes farmaceuticas que os contem
RS50045B (sr) Aktivatori glukokinaze
HRPK20020223B3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
TR200400185T4 (tr) PDE 5 inhibitörleri olarak, 8-kuinolinkisantin ve 8-izokuinolinkisantin türevleri.
NO179944C (no) Analogifremgangsmåte for fremstilling av N-fenylalkyl-substituerte <alfa>-aminokarboksamidderivater
PT98576A (pt) Processo de preparacao de derivados de benzofurano benzotiofeno indole ou indolizina assim como das composicoes que os contem
DE60228406D1 (de) PYRAZOLOÄ3,4-dÜPYRIMIDINDERIVATE UND IHRE VERWENDUNG ALS ANTAGONISTEN DES PURINERGEN REZEPTORS
ATE168102T1 (de) 1,4-benzodiazepinderivate und ihre verwendung als cck-modulatoren
RU2005135338A (ru) Замещенные 3-цианотиофенацетамиды в качестве антагонистов рецептора глюкагона
DK0869958T3 (da) Hidtil ukendte indol-2,3-dion-3-oximderivater
HRP20031091B1 (en) Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
YU21391A (sh) Triciklični-ciklični amini kao novi inhibitori holinesteraze
YU48311B (sh) Postupak za dobijanje racemskih ili optički aktivnih perhidro-1h-pirido /1,2-a/pirazina
NZ506853A (en) C11 oxymyl and hydroxylamino prostaglandins (PGF) analogs useful as medicaments
CO5170508A1 (es) Derivados mno peptidos de acetamida, como antagonistas de receptor de nk1
NZ506855A (en) C11 Oxymyl and hydroxylamino prostaglandins useful as FP agonists
ES509636A0 (es) "procedimiento para preparar nuevos compuestos de aroilimidazol-2-onas".
ATE31308T1 (de) Indolderivate.
ES517042A0 (es) Procedimiento para la preparacion de una aroilimidazolidin-2-ona.
NO985685L (no) Dibenzo-oksazepin- og -dioksazepin-derivater og deres anvendelse som anti-tumormidler
CO4700285A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion y su aplciacion en la terapeutica
DE69325239D1 (de) Überbrückte photochrome Verbindungen
DK0512939T3 (da) 2-Piperazinylbenzimidazolderivater
NO934474L (no) Krystallinske salter av optisk aktive aminokoumaranderivater, deres fremstilling og anvendelse